These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 22232282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q, Wu S, Xu T, Zhao X, Huang H, Hu F.
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L, Castello L, Di Martino A, Greco G, Legaria MC, Litterio M, Predari SC, Rollet R, Rossetti A, Carloni G, Sarchi MI, Bianchini H.
    Rev Argent Microbiol; 2007 Jun; 39(3):156-60. PubMed ID: 17987852
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.
    Ogane K, Tarumoto N, Kodana M, Onodera A, Imai K, Sakai J, Kawamura T, Takeuchi S, Murakami T, Mitsutake K, Ikebuchi K, Maesaki S, Maeda T.
    Anaerobe; 2020 Aug; 64():102215. PubMed ID: 32574601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Survey of Bacteroides fragilis group susceptibility patterns in Canada.
    Bourgault AM, Lamothe F, Hoban DJ, Dalton MT, Kibsey PC, Harding G, Smith JA, Low DE, Gilbert H.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):343-7. PubMed ID: 1605600
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction.
    Wallace MJ, Jean S, Wallace MA, Burnham CD, Dantas G.
    mBio; 2022 Feb 22; 13(1):e0360321. PubMed ID: 35038926
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
    Jeverica S, Sóki J, Premru MM, Nagy E, Papst L.
    Anaerobe; 2019 Aug 22; 58():30-34. PubMed ID: 30716401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease.
    Rashidan M, Azimirad M, Alebouyeh M, Ghobakhlou M, Asadzadeh Aghdaei H, Zali MR.
    Anaerobe; 2018 Apr 22; 50():93-100. PubMed ID: 29454108
    [Abstract] [Full Text] [Related]

  • 19. Identification of CfiA coding genes in Bacteroides fragilis isolates recovered in Argentina. Inconsistencies in CfiA organization and nomenclature.
    Litterio MR, Cejas D, Gutkind G, Radice M.
    Anaerobe; 2017 Dec 22; 48():257-261. PubMed ID: 29017951
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
    Bandoh K, Ueno K, Watanabe K, Kato N.
    Clin Infect Dis; 1993 Jun 22; 16 Suppl 4():S382-6. PubMed ID: 8324152
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.